3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
40
NIH
5
OTHER_GOV
3
INDUSTRY
3
NETWORK
2
UNKNOWN
1
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Rhabdomyosarcoma
5
Uterine Cervical Neoplasms
4
Prostatic Neoplasms
4
Medulloblastoma
4
Wilms Tumor
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neuroblastoma
3
Ganglioneuroblastoma
3
Central Nervous System Neoplasms
3
Burkitt Lymphoma
3
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Rhabdomyosarcoma, Embryonal
2
Rectal Neoplasms
2
Oropharyngeal Neoplasms
2
Gliosarcoma
2
Glioblastoma
2
Endometrial Clear Cell Adenocarcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Astrocytoma
2
Teratoma
1
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Spinal Cord Neoplasms
1
Sarcoma, Ewing
1
Rhabdomyosarcoma, Alveolar
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms
1
Interventions
Cyclophosphamide
39
Docetaxel
30
Tamoxifen
29
Paclitaxel
27
Doxorubicin
26
Trastuzumab
20
Radiotherapy
18
Epirubicin
16
Letrozole
13
exemestane
11
Fluorouracil
11
Anastrozole
11
Capecitabine
10
Bevacizumab
10
Immunohistochemistry
9
Filgrastim
9
Fulvestrant
8
Methotrexate
7
Gene Expression Profiling
7
palbociclib
6
Zoledronic Acid
6
Microarray Analysis
6
Lapatinib
6
Goserelin
6
Chemotherapy, Adjuvant
6
Amplified Fragment Length Polymorphism Analysis
6
Vinorelbine
5
Triptorelin Pamoate
5
Carboplatin
5
Absorptiometry, Photon
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
NETWORK
×
Breast Neoplasms
×
Radiation
×
Clear all
NCT03488693
2026-05-12
TAILOR RT
Canadian Cancer Trials Group
Phase 3
Recruiting
2,140 enrolled
NCT00066690
2026-02-06
SOFT
ETOP IBCSG Partners Foundation
Phase 3
Completed
3,066 enrolled
15 charts